Ignite Creation Date:
2024-05-05 @ 5:21 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00436241
Status:
COMPLETED
Last Update Posted:
2016-11-02
First Post:
2007-02-16
Brief Title:
A Study of Xeloda Capecitabine as First-Line Chemotherapy in Patients With Advanced or Metastatic Gastric Cancer
Sponsor:
Organization:
Hoffmann-La Roche